Intravenous naloxone plus transdermal buprenorphine in cancer pain associated with intractable cholestatic pruritus

J Pain Symptom Manage. 2009 Oct;38(4):e5-8. doi: 10.1016/j.jpainsymman.2009.05.008. Epub 2009 Aug 21.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Topical
  • Aged
  • Analgesics, Opioid / administration & dosage
  • Buprenorphine / administration & dosage*
  • Cholestasis / drug therapy*
  • Cholestasis / etiology
  • Chronic Disease
  • Drug Combinations
  • Female
  • Humans
  • Injections, Intravenous
  • Naloxone / administration & dosage*
  • Narcotic Antagonists / administration & dosage
  • Neoplasms / complications*
  • Neoplasms / nursing
  • Pain / etiology*
  • Pain / prevention & control*
  • Pain Measurement / drug effects
  • Palliative Care / methods
  • Pruritus / drug therapy*
  • Pruritus / etiology
  • Treatment Outcome

Substances

  • Analgesics, Opioid
  • Drug Combinations
  • Narcotic Antagonists
  • Naloxone
  • Buprenorphine